1. Home
  2. RCUS vs UTZ Comparison

RCUS vs UTZ Comparison

Compare RCUS & UTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCUS
  • UTZ
  • Stock Information
  • Founded
  • RCUS 2015
  • UTZ 2018
  • Country
  • RCUS United States
  • UTZ United States
  • Employees
  • RCUS N/A
  • UTZ N/A
  • Industry
  • RCUS Biotechnology: Pharmaceutical Preparations
  • UTZ Packaged Foods
  • Sector
  • RCUS Health Care
  • UTZ Consumer Staples
  • Exchange
  • RCUS Nasdaq
  • UTZ Nasdaq
  • Market Cap
  • RCUS 1.2B
  • UTZ 1.2B
  • IPO Year
  • RCUS 2018
  • UTZ N/A
  • Fundamental
  • Price
  • RCUS $8.17
  • UTZ $14.08
  • Analyst Decision
  • RCUS Strong Buy
  • UTZ Buy
  • Analyst Count
  • RCUS 10
  • UTZ 8
  • Target Price
  • RCUS $29.50
  • UTZ $19.25
  • AVG Volume (30 Days)
  • RCUS 907.7K
  • UTZ 1.2M
  • Earning Date
  • RCUS 05-07-2025
  • UTZ 05-01-2025
  • Dividend Yield
  • RCUS N/A
  • UTZ 1.91%
  • EPS Growth
  • RCUS N/A
  • UTZ N/A
  • EPS
  • RCUS N/A
  • UTZ 0.19
  • Revenue
  • RCUS $258,000,000.00
  • UTZ $1,409,281,000.00
  • Revenue This Year
  • RCUS N/A
  • UTZ $2.46
  • Revenue Next Year
  • RCUS $28.07
  • UTZ $2.91
  • P/E Ratio
  • RCUS N/A
  • UTZ $74.26
  • Revenue Growth
  • RCUS 120.51
  • UTZ N/A
  • 52 Week Low
  • RCUS $8.02
  • UTZ $12.71
  • 52 Week High
  • RCUS $18.98
  • UTZ $20.04
  • Technical
  • Relative Strength Index (RSI)
  • RCUS 30.17
  • UTZ 58.09
  • Support Level
  • RCUS $8.02
  • UTZ $13.52
  • Resistance Level
  • RCUS $9.19
  • UTZ $13.81
  • Average True Range (ATR)
  • RCUS 0.46
  • UTZ 0.36
  • MACD
  • RCUS 0.01
  • UTZ 0.07
  • Stochastic Oscillator
  • RCUS 7.46
  • UTZ 85.17

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About UTZ Utz Brands Inc

Utz Brands Inc is a manufacturer of branded salty snacks. It produces a broad offering of salty snacks, including potato chips, tortilla chips, pretzels, cheese snacks, pork skins, pub/party mixes, and other snacks. Its iconic portfolio of authentic, craft, and better-for-you (BFY) brands, which includes Utz, Zapp's, On The Border, Golden Flake, and Boulder Canyon, among others, enjoys household penetration in the United States, where its products can be found in approximately half of U.S. household. The company operates in eight manufacturing facilities with a broad range of capabilities, and its products are distributed nationally to grocery, mass, club, convenience, drug, e-commerce and other retailers through direct shipments, distributors, and approximately 2,500 DSD routes.

Share on Social Networks: